SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients.
Amy EvansPhil MawsonHelen L ThomasKatie KeenChristopher J E WatsonDaniel Francis McAuleyGuy A MacGowanNeil S SheerinAndrew J FisherJames A M ShawHilary YatesAndrea FallowDaphne KounaliJennifer BanksMargaret StevensRoshni PaulRenate HodgeEmma LawsonGanesh SuntharalingamJohn H DarkPublished in: BMJ open (2024)
ISRCTN11440354.